Taking aim and focused on clinical success
Talem Therapeutics is focused on the discovery and development of therapeutic antibodies targeting infectious diseases, immuno-oncology, oncology, ophthalmology and vascular disease. With direct access to world-class, expedited and end-to-end technologies, Talem accelerates preclinical development of novel therapeutic antibody treatments to the clinic through strategic alliances and partnerships.
Take your biotherapeutic programs to the next-level
Accelerating development of novel, high-priority, antibody therapies
Explore the innovative options available for out-licensing
Talem antibody experts match high value targets to fully vetted, premium therapeutic antibody programs.
Select from key targets for multiple indications, for licensing:
- From early-stage (discovery level) to IND-enabling programs
- A broad range of indications: immuno-oncology, oncology, ophthalmology, immunology, and infectious, and vascular diseases
Join us at an upcoming event
Join us at top-tier industry events below. Whether you’re seeking knowledge, partnerships, or simply looking for the latest innovations driving next-gen pharma solutions, let’s start the collaborative discussion. Don’t miss this opportunity to be part of the forefront of novel therapeutic advancements.